MAGNESIUM ASPARTATE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 132.0 | -4.5 | 1 | 4 | 108.0 | 3 | 0.5 |
- CAS
- 7018077
- UNII
- R17X820ROL
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 96 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT00663624 | Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care | Phase 4 | Withdrawn | |
| NCT01966978 | 2014-11-01 | The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study | Phase 4 | Recruiting |
| NCT02269735 | 2014-11-01 | A Two Part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Part II) (MK-2640-001) | Phase 1 | Recruiting |
| NCT02276859 | 2014-10-01 | Normal Versus Dual Wave Insulin Bolus for High-protein Food | Phase 4 | Not Yet Recruiting |
| NCT02158182 | 2014-07-01 | Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding | Phase 4 | Recruiting |
| NCT02101229 | 2014-05-01 | Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital | Phase 2/Phase 3 | Recruiting |
| NCT02131246 | 2014-05-01 | A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT02100475 | 2014-04-01 | A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification | Phase 3 | Active, Not Recruiting |
| NCT02089451 | 2014-03-01 | A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects | Phase 1 | Completed |
| NCT02043587 | 2014-01-01 | Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma | Phase 2 | Recruiting |
| NCT02033239 | 2014-01-01 | A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Aspart in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT02035371 | 2014-01-01 | A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes | Phase 1 | Completed |
| NCT02034513 | 2014-01-01 | A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes | Phase 3 | Active, Not Recruiting |
| NCT01722578 | 2013-12-01 | L-ornithine L-aspartate in Overt Hepatic Encephalopathy | Phase 4 | Recruiting |
| NCT01992588 | 2013-11-01 | A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01999322 | 2013-11-01 | A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes | Phase 3 | Completed |
| NCT02003677 | 2013-11-01 | A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Geriatric and Younger Adult Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01835431 | 2013-10-01 | A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus | Phase 3 | Completed |
| NCT01819129 | 2013-09-01 | Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes | Phase 3 | Completed |
| NCT01850615 | 2013-09-01 | Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes | Phase 3 | Completed |
| NCT01924637 | 2013-08-01 | A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01831765 | 2013-08-01 | Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes | Phase 3 | Active, Not Recruiting |
| NCT01934712 | 2013-08-01 | A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01892020 | 2013-06-01 | Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus | Phase 4 | Completed |
| NCT01814137 | 2013-03-01 | A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily | Phase 3 | Completed |
| NCT01848990 | 2013-03-01 | CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) | Phase 4 | Active, Not Recruiting |
| NCT01713530 | 2013-02-01 | A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin | Phase 3 | Completed |
| NCT01773798 | 2013-01-01 | A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01792830 | 2012-10-01 | Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft(CABG) Patients | Phase 3 | Active, Not Recruiting |
| NCT01682902 | 2012-09-01 | A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01648218 | 2012-08-01 | Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia | Phase 4 | Recruiting |
| NCT01680341 | 2012-08-01 | Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine | Phase 3 | Completed |
| NCT01561378 | 2012-08-01 | Cardiac Surgery Neuroprotection Study in Elders | Phase 2 | Completed |
| NCT01618214 | 2012-06-01 | Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes | Phase 4 | Completed |
| NCT01519674 | 2012-06-01 | Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin | Phase 4 | Completed |
| NCT01618188 | 2012-06-01 | A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01510093 | 2012-05-01 | Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II) | Phase 2 | Completed |
| NCT01589653 | 2012-05-01 | Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients | Phase 4 | Active, Not Recruiting |
| NCT01590836 | 2012-04-01 | A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01540812 | 2012-02-01 | Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS | Phase 4 | Recruiting |
| NCT01513590 | 2012-01-01 | A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes | Phase 3 | Completed |
| NCT01513473 | 2012-01-01 | A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus | Phase 3 | Completed |
| NCT01440829 | 2011-12-01 | The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS | Phase 2/Phase 3 | Completed |
| NCT01526733 | 2011-12-01 | Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase | Phase 4 | Completed |
| NCT00700362 | 2011-12-01 | Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU) | Phase 4 | Withdrawn |
| NCT01474538 | 2011-12-01 | Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy | Phase 3 | Completed |
| NCT01486966 | 2011-11-01 | Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes | Phase 4 | Terminated |
| NCT01469143 | 2011-11-01 | A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01455142 | 2011-10-01 | A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01417897 | 2011-09-01 | Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study | Phase 4 | Active, Not Recruiting |
| NCT01388361 | 2011-09-01 | Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin | Phase 3 | Completed |
| NCT01427920 | 2011-09-01 | Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes | Phase 4 | Completed |
| NCT01678235 | 2011-09-01 | Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus | Phase 4 | Completed |
| NCT01445951 | 2011-09-01 | Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period | Phase 3 | Completed |
| NCT01365507 | 2011-06-01 | Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens | Phase 3 | Completed |
| NCT01407289 | 2011-06-01 | A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia | Phase 4 | Completed |
| NCT01333514 | 2011-04-01 | Carbohydrate Consumption as a Factor in Aspart Dosing | Phase 4 | Completed |
| NCT01399346 | 2011-04-01 | Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01215435 | 2011-03-01 | Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone | Phase 4 | Completed |
| NCT01242826 | 2011-02-01 | Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese Subjects | Phase 1 | Completed |
| NCT01296438 | 2011-02-01 | A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1 | Phase 1 | Completed |
| NCT01275131 | 2011-01-01 | Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM) | Phase 1 | Completed |
| NCT01272193 | 2011-01-01 | Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjets With Type 2 Diabetes | Phase 3 | Completed |
| NCT01501149 | 2011-01-01 | Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ | Phase 4 | Recruiting |
| NCT01278160 | 2011-01-01 | Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756 | Phase 4 | Completed |
| NCT01269606 | 2011-01-01 | Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01134107 | 2010-11-01 | Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use | Phase 3 | Completed |
| NCT01165684 | 2010-10-01 | Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen | Phase 4 | Completed |
| NCT01196104 | 2010-09-01 | Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler | Phase 3 | Terminated |
| NCT01190956 | 2010-09-01 | Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes: An Extension Trial to NN1250-3585 | Phase 3 | Completed |
| NCT01212913 | 2010-08-01 | Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM) | Phase 4 | Completed |
| NCT01194245 | 2010-08-01 | Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus | Phase 2 | Completed |
| NCT01194258 | 2010-08-01 | Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus | Phase 2 | Completed |
| NCT01174303 | 2010-08-01 | A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01173926 | 2010-07-01 | Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01293396 | 2010-06-01 | Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids | Phase 4 | Completed |
| NCT01138488 | 2010-06-01 | A Trial Investigating the Total Exposure of NN5401 in Children, Adolescents and Adult Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01101867 | 2010-06-01 | Prandial Insulin Dosing in Hospitalized Patients | Phase 4 | Completed |
| NCT01134224 | 2010-05-01 | A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes | Phase 1 | Completed |
| NCT01125553 | 2010-05-01 | A Comparison Between Two Formulations of NN5401 in Healthy Subjects | Phase 1 | Completed |
| NCT01123980 | 2010-05-01 | Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment | Phase 4 | Completed |
| NCT01121276 | 2010-04-01 | A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes | Phase 1 | Completed |
| NCT01121289 | 2010-04-01 | A Trial Investigating NN1218 in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01109316 | 2010-04-01 | Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use | Phase 3 | Completed |
| NCT01079234 | 2010-03-01 | Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes | Phase 3 | Completed |
| NCT01068652 | 2010-03-01 | Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs | Phase 4 | Completed |
| NCT01074268 | 2010-02-01 | Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes | Phase 3 | Completed |
| NCT01059812 | 2010-02-01 | A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes | Phase 3 | Completed |
| NCT01045447 | 2010-01-01 | Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes | Phase 3 | Completed |
| NCT01051102 | 2010-01-01 | Effect of NN5401 in Japanese Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01828970 | 2010-01-01 | Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients | Phase 4 | Completed |
| NCT01045707 | 2010-01-01 | Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes | Phase 3 | Completed |
| NCT00791102 | 2010-01-01 | Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC) | Phase 2/Phase 3 | Completed |
| NCT01079364 | 2010-01-01 | Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting | Phase 4 | Terminated |
| NCT01041755 | 2009-12-01 | Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy. | Phase 4 | Completed |
| NCT01009580 | 2009-11-01 | Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes | Phase 3 | Completed |
| NCT01028404 | 2009-11-01 | A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes | Phase 1 | Completed |
| NCT00992537 | 2009-10-01 | Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics | Phase 1 | Completed |
| NCT00993096 | 2009-09-01 | Investigation of the Response Relationship of NN5401 in Type 1 Diabetics | Phase 1 | Completed |
| NCT00972283 | 2009-09-01 | Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes | Phase 3 | Completed |
| NCT00979875 | 2009-09-01 | A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone | Phase 1 | Completed |
| NCT00982228 | 2009-09-01 | Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes | Phase 3 | Completed |
| NCT00978627 | 2009-08-01 | Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes | Phase 3 | Completed |
| NCT00850161 | 2009-07-01 | Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin | Phase 2 | Withdrawn |
| NCT00965549 | 2009-07-01 | Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients | Phase 4 | Completed |
| NCT00913497 | 2009-06-01 | The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children | Phase 4 | Completed |
| NCT00888732 | 2009-06-01 | A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin | Phase 3 | Completed |
| NCT00933673 | 2009-06-01 | New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma | Phase 2 | Recruiting |
| NCT00906529 | 2009-05-01 | Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin | Phase 4 | Recruiting |
| NCT00942318 | 2009-03-01 | Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes | Phase 4 | Completed |
| NCT00821795 | 2009-02-01 | Veterans Inpatient Insulin Study and Transition to Outpatient Therapy | Phase 4 | Completed |
| NCT00842361 | 2009-01-01 | Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus | Phase 2 | Completed |
| NCT00841087 | 2009-01-01 | Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes | Phase 2 | Completed |
| NCT00807092 | 2008-12-01 | Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes | Phase 4 | Completed |
| NCT00896831 | 2008-11-01 | Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy | Phase 4 | Enrolling By Invitation |
| NCT00797823 | 2008-11-01 | Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone | Phase 2 | Completed |
| NCT00785811 | 2008-10-01 | Effect of Chronic Supplementation of L-arginine in the Muscular Performance | Phase 4 | Terminated |
| NCT00740142 | 2008-09-01 | Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy | Phase 4 | Recruiting |
| NCT01464099 | 2008-06-01 | Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01868581 | 2008-05-01 | Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy Subjects | Phase 1 | Completed |
| NCT00591227 | 2008-05-01 | Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol. | Phase 4 | Completed |
| NCT01868568 | 2008-04-01 | Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT00657943 | 2008-04-01 | The Copenhagen Insulin and Metformin Therapy Trial | Phase 4 | Completed |
| NCT00623194 | 2008-02-01 | Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689 | Phase 3 | Completed |
| NCT00627445 | 2008-02-01 | Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes | Phase 3 | Completed |
| NCT00614055 | 2008-01-01 | Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes | Phase 2 | Completed |
| NCT00613951 | 2008-01-01 | Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes | Phase 2 | Completed |
| NCT00612040 | 2008-01-01 | Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes | Phase 2 | Completed |
| NCT00607087 | 2008-01-01 | Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus | Phase 4 | Completed |
| NCT01868555 | 2007-12-01 | Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects | Phase 1 | Completed |
| NCT00969592 | 2007-11-01 | Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers | Phase 1 | Completed |
| NCT00669864 | 2007-11-01 | Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin | Phase 4 | Completed |
| NCT00537303 | 2007-10-01 | Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes | Phase 4 | Completed |
| NCT00537277 | 2007-10-01 | Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs | Phase 4 | Completed |
| NCT00581867 | 2007-10-01 | Memory and Insulin in Early Alzheimer's Disease | Phase 2 | Completed |
| NCT01159353 | 2007-09-01 | Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart | Phase 1 | Completed |
| NCT00542620 | 2007-09-01 | Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial | Phase 4 | Completed |
| NCT00523042 | 2007-08-01 | Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma | Phase 3 | Terminated |
| NCT00824668 | 2007-08-01 | Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes | Phase 1 | Completed |
| NCT00497536 | 2007-07-01 | Pharmacokinetics of IAsp Following CSII in Patients With T1DM | Phase 4 | Completed |
| NCT00505882 | 2007-07-01 | Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes | Phase 4 | Withdrawn |
| NCT00509925 | 2007-07-01 | Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes | Phase 4 | Terminated |
| NCT00998335 | 2007-06-01 | Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes | Phase 4 | Completed |
| NCT00469092 | 2007-05-01 | Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes | Phase 4 | Completed |
| NCT00346996 | 2007-05-01 | Insulin Analogues and Severe Hypoglycaemia | Phase 4 | Completed |
| NCT00472953 | 2007-05-01 | Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Terminated |
| NCT00467649 | 2007-05-01 | A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes | Phase 4 | Completed |
| NCT00474045 | 2007-05-01 | Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes | Phase 3 | Completed |
| NCT00473967 | 2007-05-01 | Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults | Phase 1 | Terminated |
| NCT00771693 | 2007-05-01 | Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM) | Phase 4 | Completed |
| NCT00476437 | 2007-04-01 | Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus. | Phase 3 | Completed |
| NCT00449839 | 2007-04-01 | Changes of the Infusion Rate in Insulin Pump Treatment | Phase 4 | Completed |
| NCT00447382 | 2007-03-01 | Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes | Phase 3 | Completed |
| NCT00825253 | 2007-03-01 | Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes | Phase 1 | Completed |
| NCT00435019 | 2007-02-01 | Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes | Phase 3 | Completed |
| NCT00434954 | 2007-02-01 | Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes | Phase 3 | Completed |
| NCT00590226 | 2006-12-01 | Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes | Phase 4 | Completed |
| NCT01865331 | 2006-12-01 | Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects | Phase 1 | Completed |
| NCT00393705 | 2006-10-01 | Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019) | Phase 4 | Completed |
| NCT01865305 | 2006-09-01 | Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes | Phase 1 | Completed |
| NCT00331604 | 2006-08-01 | Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes | Phase 3 | Terminated |
| NCT00353990 | 2006-08-01 | Bioavailability of Insulin Administered in Duodenum | Phase 1/Phase 2 | Completed |
| NCT01538511 | 2006-06-01 | Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers | Phase 1 | Completed |
| NCT00322257 | 2006-05-01 | Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes | Phase 3 | Terminated |
| NCT01536028 | 2006-04-01 | Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT00313001 | 2006-04-01 | Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea. | Phase 3 | Completed |
| NCT00318786 | 2006-04-01 | Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes | Phase 3 | Completed |
| NCT01530048 | 2006-03-01 | Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL) | Phase 1 | Completed |
| NCT00282451 | 2006-02-01 | Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes | Phase 4 | Completed |
| NCT00309244 | 2006-02-01 | Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up | Phase 3 | Completed |
| NCT00267683 | 2005-12-01 | Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes | Phase 3 | Terminated |
| NCT01486862 | 2005-10-01 | Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs | Phase 4 | Completed |
| NCT00202605 | 2005-09-01 | Safety and Efficacy of SPD465 in Adults With ADHD | Phase 2 | Completed |
| NCT00274274 | 2005-09-01 | Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes | Phase 4 | Completed |
| NCT00184561 | 2005-07-01 | Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes | Phase 4 | Completed |
| NCT00115973 | 2005-06-01 | A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump | Phase 1 | Completed |
| NCT00117780 | 2005-06-01 | Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes | Phase 4 | Completed |
| NCT01487811 | 2005-05-01 | Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers | Phase 1 | Completed |
| NCT00184613 | 2005-05-01 | Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes | Phase 1 | Completed |
| NCT00184574 | 2005-04-01 | Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes | Phase 3 | Completed |
| NCT00152022 | 2005-04-01 | Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD. | Phase 3 | Completed |
| NCT00120081 | 2005-04-01 | Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection | Phase 1 | Completed |
| NCT00504673 | 2005-04-01 | Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes | Phase 3 | Completed |
| NCT00152035 | 2005-03-01 | Safety of SPD465 in Treating Adults With ADHD. | Phase 3 | Completed |
| NCT00254085 | 2005-03-01 | Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes. | Phase 4 | Recruiting |
| NCT00106366 | 2005-03-01 | Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes | Phase 3 | Completed |
| NCT00470314 | 2005-01-01 | Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure | Phase 2 | Active, Not Recruiting |
| NCT00097877 | 2005-01-01 | Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes | Phase 3 | Completed |
| NCT00150579 | 2005-01-01 | Efficacy and Safety of SPD465 in Adults With ADHD | Phase 3 | Completed |
| NCT00494988 | 2004-12-01 | Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart | Phase 4 | Completed |
| NCT00184600 | 2004-11-01 | Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes | Phase 3 | Completed |
| NCT00101751 | 2004-10-01 | INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study | Phase 4 | Completed |
| NCT00097071 | 2004-10-01 | Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents | Phase 3 | Completed |
| NCT00461331 | 2004-10-01 | Comparison of Insulins Aspart and Lispro in Insulin Pumps | Phase 4 | Completed |
| NCT00097084 | 2004-09-01 | Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes | Phase 3 | Completed |
| NCT00184626 | 2004-09-01 | Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes. | Phase 4 | Completed |
| NCT00095082 | 2004-09-01 | Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes | Phase 3 | Completed |
| NCT00097279 | 2004-08-01 | Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes | Phase 3 | Completed |
| NCT00747409 | 2004-07-01 | Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes | Phase 4 | Active, Not Recruiting |
| NCT00095446 | 2004-07-01 | NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes | Phase 4 | Completed |
| NCT00593255 | 2004-07-01 | Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes | Phase 4 | Completed |
| NCT00184665 | 2004-06-01 | Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes | Phase 3 | Completed |
| NCT00564668 | 2004-06-01 | Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes | Phase 3 | Completed |
| NCT00624364 | 2004-05-01 | Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes | Phase 4 | Completed |
| NCT00500240 | 2004-04-01 | Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) | Phase 3 | Terminated |
| NCT00600366 | 2004-03-01 | Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes | Phase 4 | Completed |
| NCT00600626 | 2004-01-01 | Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes | Phase 4 | Completed |
| NCT00619697 | 2003-12-01 | Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes | Phase 4 | Completed |
| NCT00605020 | 2003-12-01 | Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes | Phase 3 | Completed |
| NCT00592969 | 2003-12-01 | Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes | Phase 4 | Completed |
| NCT01527656 | 2003-12-01 | Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects | Phase 1 | Completed |
| NCT00595374 | 2003-12-01 | Efficacy and Safety of Insulin Detemir in Type 1 Diabetes | Phase 3 | Completed |
| NCT00605111 | 2003-12-01 | Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes | Phase 4 | Completed |
| NCT01527643 | 2003-11-01 | Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects | Phase 1 | Completed |
| NCT00280046 | 2003-11-01 | Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes | Phase 4 | Completed |
| NCT00082407 | 2003-11-01 | Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin | Phase 3 | Completed |
| NCT01620437 | 2003-11-01 | Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects | Phase 1 | Completed |
| NCT00433368 | 2003-10-01 | Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy | Phase 3 | Completed |
| NCT00612599 | 2003-09-01 | Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes | Phase 3 | Completed |
| NCT00571935 | 2003-08-01 | Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes | Phase 4 | Completed |
| NCT00617565 | 2003-07-01 | Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes | Phase 3 | Completed |
| NCT00791895 | 2003-06-01 | Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs | Phase 4 | Completed |
| NCT00604656 | 2003-05-01 | Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes | Phase 3 | Completed |
| NCT00572806 | 2003-02-01 | Initiation of Insulin Aspart in Type 2 Diabetes | Phase 4 | Completed |
| NCT00853008 | 2003-01-01 | Treatment of High Risk Adult Acute Lymphoblastic Leukemia | Phase 4 | Recruiting |
| NCT01486914 | 2003-01-01 | Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process | Phase 1 | Completed |
| NCT01527565 | 2003-01-01 | Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects | Phase 1 | Completed |
| NCT00121966 | 2003-01-01 | South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus | Phase 4 | Completed |
| NCT01527552 | 2002-11-01 | Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects | Phase 1 | Completed |
| NCT00598793 | 2002-11-01 | Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy | Phase 4 | Completed |
| NCT01527630 | 2002-11-01 | Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects | Phase 1 | Completed |
| NCT00597233 | 2002-10-01 | Human Insulin NPH and Insulin Aspart in Type 1 Diabetes | Phase 4 | Completed |
| NCT00365170 | 2002-09-01 | Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes | Phase 4 | Completed |
| NCT01698697 | 2002-09-01 | Comparison of Two Insulin Aspart Formulations in Healthy Volunteers | Phase 1 | Completed |
| NCT00725036 | 2002-09-01 | Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes | Phase 3 | Completed |
| NCT01467401 | 2002-08-01 | Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes | Phase 4 | Completed |
| NCT00312156 | 2002-08-01 | Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes | Phase 3 | Completed |
| NCT01697631 | 2002-07-01 | Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes | Phase 4 | Completed |
| NCT01487798 | 2002-06-01 | Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes | Phase 4 | Completed |
| NCT00071448 | 2002-06-01 | Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population | Phase 3 | Completed |
| NCT01467141 | 2002-06-01 | Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes | Phase 4 | Completed |
| NCT01526980 | 2002-05-01 | Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes | Phase 2 | Completed |
| NCT00312104 | 2002-04-01 | Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes | Phase 3 | Completed |
| NCT00513643 | 2002-04-01 | Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses | Phase 1 | Completed |
| NCT01486940 | 2002-03-01 | Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes | Phase 3 | Completed |
| NCT01649570 | 2002-03-01 | Safety and Efficacy of Insulin Aspart in Type 2 Diabetes | Phase 4 | Completed |
| NCT01486381 | 2002-03-01 | Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes | Phase 3 | Completed |
| NCT00676819 | 2002-01-01 | Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes | Phase 4 | Completed |
| NCT01527539 | 2001-11-01 | Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes | Phase 3 | Completed |
| NCT01697657 | 2001-09-01 | Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes | Phase 3 | Completed |
| NCT00072904 | 2001-06-01 | Diabetes Therapy to Improve BMI and Lung Function in CF | Phase 3 | Completed |
| NCT01526941 | 2001-05-01 | Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01704378 | 2001-04-01 | Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes | Phase 4 | Completed |
| NCT01620424 | 2001-02-01 | Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes | Phase 1 | Completed |
| NCT01524809 | 2001-01-01 | Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes | Phase 1 | Completed |
| NCT01467375 | 2001-01-01 | Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes | Phase 3 | Completed |
| NCT01650129 | 2000-12-01 | Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes | Phase 3 | Completed |
| NCT00065130 | 2000-04-01 | Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes | Phase 3 | Completed |
| NCT01520818 | 2000-03-01 | Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes | Phase 3 | Completed |
| NCT01620333 | 2000-02-01 | Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers | Phase 1 | Completed |
| NCT00832182 | 1999-12-01 | Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes | Phase 3 | Completed |
| NCT01523041 | 1999-11-01 | Comparison of Two Formulations of Biphasic Insulin Aspart 70 | Phase 1 | Completed |
| NCT01520831 | 1999-04-01 | Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects | Phase 1 | Completed |
| NCT01520753 | 1999-03-01 | Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes | Phase 3 | Completed |
| NCT01467323 | 1998-04-01 | Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes | Phase 3 | Completed |
| NCT01707134 | 1997-09-01 | Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes | Phase 3 | Completed |
| NCT01697618 | 1997-04-01 | Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes | Phase 2 | Completed |
| NCT01707160 | 1995-11-01 | Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers | Phase 1 | Completed |
| NCT00410033 | 1989-12-01 | Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin | Phase 3 | Completed |